Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

24.80
Delayed Data
As of Sep 03
 -0.26 / -1.04%
Today’s Change
11.34
Today|||52-Week Range
39.80
-35.67%
Year-to-Date
No recent news for Paratek Pharmaceuticals Inc.

Today’s Trading

Previous close25.06
Today’s open25.14
Day’s range24.65 - 26.15
Volume40,093
Average volume (3 months)98,390
Market cap$440.1M
Dividend yield2.70%
Data as of 09/03/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+56.62%
Earnings growth (next 5 years)+545.30%
Revenue growth (last year)--
P/E ratioNM
Price/Sales22.45
Price/Book3.79

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...-0.45-4.99%
IGIGI Laboratories Inc-0.04-0.48%
SPPISpectrum Pharmaceuti...-0.25-3.78%
ADXSAdvaxis Inc-0.32-2.33%
Data as of 09/03/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.90
Annual revenue (last year)$4.3M
Annual profit (last year)-$17.8M
Net profit margin-410.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, Director &
Chief Medical Officer
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers